NEW YORK, Jan. 5 (GenomeWeb News) - Denmark's Exiqon has licensed certain rights to its locked nucleic acid technology to Integrated DNA Technologies (IDT), the companies said today.
Â
Under the terms of the deal, IDT has non-exclusive rights to manufacture and sell locked nucleic acid oligonucleotides for the genomics research market and will receive access to certain Exiqon know-how related to the technology.
Â
Financial terms of the arrangement were not disclosed.
Â
According to the companies, a locked nucleic acid is a proprietary nucleic acid analog that is easily incorporated into synthetic DNA oligos. Locked nucleic acid probes, they added, have successfully been used in both RT-PCR-based expression profiling and SNP genotyping assays, as well as in expression microarrays and siRNA oligos for target validation.